Sign in

CIK 0001649094

  • Large accelerated filer

Vaxcyte, Inc.

Sign in to watch
Ticker
PCVX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464233385
Phone
+1 650-837-0111
Business address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
Former names
SutroVax, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,185,988
in 8 filings, $4.8M under 10b5-1 plans

Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 88 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-15 Lukatch Heath Director Grant or award +2,265 19,481
2026-06-15 Lukatch Heath Director Grant or award · Stock Option (right to buy) +11,389 11,389
2025-06-12 Lukatch Heath Director Grant or award +3,041 17,216
2025-06-12 Lukatch Heath Director Grant or award · Stock Option (right to buy) +15,372 15,372
2025-04-08 Lukatch Heath Director Option exercise +6,000 $16.00 $96K 13,175
2025-04-08 Lukatch Heath Director Option exercise +1,000 $21.49 $21K 14,175
2025-04-08 Lukatch Heath Director Option exercise · Stock Option (right to buy) −6,000 0
2025-04-08 Lukatch Heath Director Option exercise · Stock Option (right to buy) −1,000 14,000
2024-06-06 Lukatch Heath Director Grant or award +1,550 7,175
2024-06-06 Lukatch Heath Director Grant or award · Stock Option (right to buy) +7,250 7,250
2024-01-31 Lukatch Heath Director Option exercise 10b5-1 +5,000 $16.00 $80K 10,625
2024-01-31 Lukatch Heath Director Sale 10b5-1 −5,000 $71.50 $358K 5,625
2024-01-31 Lukatch Heath Director Option exercise · Stock Option (right to buy) 10b5-1 −5,000 6,000
2024-01-29 Lukatch Heath Director Option exercise 10b5-1 +4,000 $16.00 $64K 9,625
2024-01-29 Lukatch Heath Director Sale 10b5-1 −4,000 $67.50 $270K 5,625
2024-01-29 Lukatch Heath Director Option exercise · Stock Option (right to buy) 10b5-1 −4,000 11,000
2024-01-02 Lukatch Heath Director Option exercise 10b5-1 +13,000 $16.00 $208K 18,625
2024-01-02 Lukatch Heath Director Sale 10b5-1 −1,101 $62.85 $69K 17,524
2024-01-02 Lukatch Heath Director Sale 10b5-1 −7,444 $63.55 $473K 10,080
2024-01-02 Lukatch Heath Director Sale 10b5-1 −4,164 $64.28 $268K 5,916

Page 1 of 3 · 44 trades